Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

AstraZeneca to sell anti-psychotic medicine rights in Europe and Russia for $239m
Pharmaceutical Business Review
Thu, 10/31/19 - 10:14 am
Tags:
AstraZeneca, Seroquel, antipsychotic, Europe, Russia, Cheplapharm
AstraZeneca, on BMS' heels, scores lung cancer win with Imfinzi combos
Fierce Pharma
Tue, 10/29/19 - 10:25 am
Tags:
AstraZeneca, Imfinizi, non-small cell lung cancer
AstraZeneca Beats Expectations, China Momentum Continues — Earnings Review
Morningstar
Thu, 10/24/19 - 10:41 am
Tags:
AstraZeneca, earnings
AstraZeneca dumps phase 3 renal cell carcinoma program
Fierce Biotech
Thu, 10/24/19 - 10:23 am
Tags:
AstraZeneca, savolitinib, renal cell carcinoma
What's in the Cards for AstraZeneca (AZN) in Q3 Earnings?
Yahoo/Zacks.com
Tue, 10/22/19 - 10:36 am
Tags:
earnings, AstraZeneca
AstraZeneca's Farxiga scores FDA nod to cut risk of hospitalization for heart failure in diabetics
Endpoints
Mon, 10/21/19 - 10:08 am
Tags:
AstraZeneca, Farxiga, type 1 diabetes, heart failure
A change of the guard for the world’s biggest cancer companies
EP Vantage
Fri, 10/18/19 - 10:16 am
Tags:
cancer, Bristol-Myers Squibb, Celgene, M&A, Roche, AstraZeneca
AstraZeneca gets Q2 2020 PDUFA date for breast cancer ADC
Fierce Biotech
Thu, 10/17/19 - 10:48 am
Tags:
AstraZeneca, FDA, antibody-drug conjugate, trastuzumab deruxtecan, breast cancer
MedImmune's top cancer researcher jumps ship to small biotech
Fierce Biotech
Wed, 10/16/19 - 12:26 pm
Tags:
R&D, MedImmune, AstraZeneca, Pyxis Oncology
AZ got past FluMist's efficacy woes, but now it's plagued by production problems
Fierce Pharma
Mon, 10/14/19 - 11:58 pm
Tags:
AstraZeneca, FluMist
ImaginAb joins with AZ, Pfizer and Takeda to develop tumour imaging tech
Pharmaforum
Mon, 10/14/19 - 09:50 am
Tags:
ImaginAb, tumor imaging, AstraZeneca, Pfizer, Takeda
Big Pharma giving more money to patient advocacy groups
Beckers Hospital Review
Wed, 10/9/19 - 11:14 pm
Tags:
Big Pharma, JNJ, AbbVie, Bristol-Myers Squibb, Pfizer, Merck, AstraZeneca, patient advocacy groups
Lilly touts Cyramza lung cancer data, as AZ’s Tagrisso grows even more powerful
Fierce Pharma
Mon, 10/7/19 - 12:18 pm
Tags:
EGFR lung cancer, lung cancer, Eli Lilly, Cyramza, AstraZeneca, Tagrisso
FDA green lights AstraZeneca's asthma drug Fasenra for self-administration
Yahoo/Reuters
Fri, 10/4/19 - 10:25 am
Tags:
AstraZeneca, FDA, asthma, Fasenra
As its oncology effort gathers steam, AstraZeneca sheds another legacy drug
Endpoints
Wed, 10/2/19 - 10:48 am
Tags:
AstraZeneca, Losec
AstraZeneca's combo lung disease therapy fails to win FDA approval
Reuters
Tue, 10/1/19 - 10:35 am
Tags:
AstraZeneca, FDA, COPD, PT010
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
Xconomy
Tue, 10/1/19 - 10:29 am
Tags:
ESMO, PARP inhibitors, prostate cancer, KRAS, Seattle Genetics, AstraZeneca, Merck, GSK, Amgen, breast cancer, Roche, Pfizer
ESMO: AstraZeneca eyes payer boost with Tagrisso's latest survival win
Fierce Pharma
Sun, 09/29/19 - 09:29 pm
Tags:
AstraZeneca, Tagrisso, EGFR lung cancer, ESMO
Separate GSK, AstraZeneca trial results may widen ovarian cancer drug use
Yahoo/Reuters
Sun, 09/29/19 - 11:57 am
Tags:
GSK, AstraZeneca, ESMO, ovarianc cancer, PARP inhibitors, Lynparza, Zejula
AstraZeneca strengthens lead in PARP drug class
Biopharma Dive
Sat, 09/28/19 - 05:00 pm
Tags:
AstraZeneca, Merck, Lynparza, ovarian cancer, PARP inhibitors, veliparib

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.